In preparation for this experiment, researchers analyzed levels of CCR7 expression in breast cancer cell lines, observing that CCR7 levels are mainly upregulated in the triple-negative 4T1 mouse mammary cancer cell line and to a less appreciable degree in the human triple-negative breast cancer MDA-MB-231 cell line. The gene discussed is CCR7; the disease is triple-negative breast carcinoma.